CoChat

Approaching clinical proteomics: current state and future fields of application in fluid proteomics

Open access
Apweiler, Rolf, Aslanidis, Charalampos, Deufel, Thomas, Gerstner, Andreas, Hansen, Jens, Hochstrasser, Dennis, Kellner, Roland, Kubicek, Markus, Lottspeich, Friedrich, Maser, Edmund, Mewes, Hans-Werner, Meyer, Helmut E., Müllner, Stefan, Mutter, Wolfgang, Neumaier, Michael, Nollau, Peter, Nothwang, Hans G., Ponten, Fredrik, Radbruch, Andreas, Reinert, Knut, Rothe, Gregor, Stockinger, Hannes, Tarnok, Attila, Taussig, Mike J., Thiel, Andreas, Thiery, Joachim, Ueffing, Marius, Valet, Günther, Vandekerckhove, Joel, Verhuven, Wiltrud, Wagener, Christoph, Wagner, Oswald, Schmitz, Gerd · 2009 · Clinical Chemistry and Laboratory Medicine
Cited by 138

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The field of clinical proteomics offers opportunities to identify new disease biomarkers in body fluids, cells and tissues. These biomarkers can be used in clinical applications for diagnosis, stratification of patients for specific treatment, or therapy monitoring. New protein array formats and improved spectrometry technologies have brought these analyses to a level with potential for use in clinical diagnostics. The nature of the human body fluid proteome with its large dynamic range of protein concentrations presents problems with quantitation. The extreme complexity of the proteome in body fluids presents enormous challenges and requires the establishment of standard operating procedures for handling of specimens, increasing sensitivity for detection and bioinformatical tools for distribution of proteomic data into the public domain. From studies of in vitro diagnostics, especially in clinical chemistry, it is evident that most errors occur in the preanalytical phase and during implementation of the diagnostic strategy. This is also true for clinical proteomics, and especially for fluid proteomics because of the multiple pretreatment processes. These processes include depletion of high-abundance proteins from plasma or enrichment processes for urine where biological variation or differences in proteolytic activities in the sample along with preanalytical variables such as inter- and intra-assay variability will likely influence the results of proteomics studies. However, before proteomic analysis can be introduced at a broader level into the clinical setting, standardization of the preanalytical phase including patient preparation, sample collection, sample preparation, sample storage, measurement and data analysis needs to be improved. In this review, we discuss the recent technological advances and applications that fulfil the criteria for clinical proteomics, with the focus on fluid proteomics. These advances relate to preanalytical factors, analytical standardization and quality-control measures required for effective implementation into routine laboratory testing in order to generate clinically useful information. With new disease biomarker candidates, it will be crucial to design and perform clinical studies that can identify novel diagnostic strategies based on these techniques, and to validate their impact on clinical decision-making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm.2009.167

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Apweiler, R., Aslanidis, C., Deufel, T., Gerstner, A., Hansen, J., Hochstrasser, D., Kellner, R., Kubicek, M., Lottspeich, F., Maser, E., Mewes, H.-W., Meyer, H. E., Müllner, S., Mutter, W., Neumaier, M., Nollau, P., Nothwang, H. G., Ponten, F., Radbruch, A., Reinert, K., Rothe, G., Stockinger, H., Tarnok, A., Taussig, M. J., Thiel, A., Thiery, J., Ueffing, M., Valet, G., Vandekerckhove, J., Verhuven, W., Wagener, C., Wagner, O., & Schmitz, G.
Venue
Clinical Chemistry and Laboratory Medicine
Published
2009-01-01
Volume
47
Issue
6
Pages
724-44
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W3023267721
Cited by
138
References
4
FWCI
8.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.